Added Value of a Robotic-assisted Bronchoscopy Platform in Cone Beam Computed Tomography-guided Bronchoscopy for the Diagnosis of Pulmonary Parenchymal Lesions.

Autor:	Shaller BD; Division of Pulmonary, Allergy and Critical Care Medicine, Stanford University School of Medicine, Stanford, CA., Duong DK; Inova Interventional Pulmonology and Complex Airways Disease Program, Division of Thoracic Surgery, Inova Fairfax Medical Campus, Falls Church, VA., Swenson KE; Division of Thoracic Surgery and Interventional Pulmonology, Beth Israel Deaconess Medical Center, Boston, MA., Free D; Department of Respiratory Care Services, Stanford Health Care, Stanford, CA., Bedi H; Division of Pulmonary, Allergy and Critical Care Medicine, Stanford University School of Medicine, Stanford, CA.
Jazyk:	angličtina
Zdroj:	Journal of bronchology & interventional pulmonology [J Bronchology Interv Pulmonol] 2024 Jun 27; Vol. 31 (3). Date of Electronic Publication: 2024 Jun 27 (Print Publication: 2024).
DOI:	10.1097/LBR.0000000000000971
Abstrakt:	Background: Cone beam computed tomography (CBCT)-guided bronchoscopic sampling of peripheral pulmonary lesions (PPLs) is associated with superior diagnostic outcomes. However, the added value of a robotic-assisted bronchoscopy platform in CBCT-guided diagnostic procedures is unknown. Methods: We performed a retrospective review of 100 consecutive PPLs sampled using conventional flexible bronchoscopy under CBCT guidance (FB-CBCT) and 100 consecutive PPLs sampled using an electromagnetic navigation-guided robotic-assisted bronchoscopy platform under CBCT guidance (RB-CBCT). Patient demographics, PPL features, procedural characteristics, and procedural outcomes were compared between the 2 cohorts. Results: Patient and PPL characteristics were similar between the FB-CBCT and RB-CBCT cohorts, and there were no significant differences in diagnostic yield (88% vs. 90% for RB-CBCT, P=0.822) or incidence of complications between the 2 groups. As compared with FB-CBCT cases, RB-CBCT cases were significantly shorter (median 58 min vs. 92 min, P<0.0001) and used significantly less diagnostic radiation (median dose area product 5114 µGy•m2 vs. 8755 µGy•m2, P<0.0001). Conclusion: CBCT-guided bronchoscopy with or without a robotic-assisted bronchoscopy platform is a safe and effective method for sampling PPLs, although the integration of a robotic-assisted platform was associated with significantly shorter procedure times and significantly less radiation exposure. (Copyright © 2024 Wolters Kluwer Health, Inc. All rights reserved.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu